Limited data are available with regard to overdosage in humans. In clinical studies in
volunteers, AVANDIA has been administered at single oral doses of up to 20 mg and was
well-tolerated. In the event of an overdose, appropriate supportive treatment should be initiated
as dictated by the patient’s clinical status.
Adapted from the FDA Package Insert.